ClinicalTrials.gg
Status unknownNCT05026190Updated Aug 30, 2021

Role of Transrectal-ultrasound in Evaluation of Azoospermia

An interventional study of transrectal ultrasound in Infertility Due to Azoospermia, sponsored by Assiut University. Status unknown. Open to male participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-08-30.

Sponsored by Assiut University · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Aug 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
18 Years to 60 Years
Sex
Male
01

Study summary

Azoospermia is a word meaning to ejaculates with no spermatozoa without a definite underlying cause .1% of men has azoospermia, representing nearly 10 to 15% of all infertile men. The azoospermia is a major concern in our community. There is no actual epidemiological studies to estimate the actual numbers in Egypt. Azoospermia has several classifications, pre-testicular, testicular \& post-testicular cause .The semen analysis is the main investigation done for these patient .The treatment methods range from hormonal therapy to surgery or ICSI . The imaging modalities has developed greatly in the last 3 decades. That it became in several setting as a bedside test or investigation. The main modalities used in azoospermia are scrotal ultrasound, TRUS and MRI. The first TRUS was introduced 1957.

02

Conditions studied

  • Infertility Due to Azoospermia
03

In context

Azoospermia

59 studies on the registry are indexed under Azoospermia; 17 are open to participants now.

This study's planned enrollment of 50 is below the median of 57 across 32 interventional studies indexed under Azoospermia.

Browse Azoospermia studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Adult patients with azoospermia as identified by semen analysis.

      • Age from 18 years to more

Exclusion criteria

Exclusion Criteria:

    • History of operative intervention in the lower urinary tract.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Other
    azoospermic patients

    Diagnostic Test: transrectal ultrasound

Interventions

  • Diagnostic testtransrectal ultrasound

    we perform trus to identify the cause of azospermia and its type either obstructive or not

06

What researchers measure

Primary outcomes

  1. Number of patients With obstructive azoospermia

    Time frame: through study completion ,within average one year.

  2. Number of patient with non obstructive azoospermia

    Time frame: through study completion , within average one year.

  3. Number of patient that will respond to endoscopic treatment

    Time frame: 6 month duration

  4. Number of patients that will need sperm extraction

    Time frame: 9 month duration

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Aziz N. The importance of semen analysis in the context of azoospermia. Clinics (Sao Paulo). 2013;68 Suppl 1(Suppl 1):35-8. doi: 10.6061/clinics/2013(sup01)05. PubMed 23503953 ↗
  • Gudeloglu A, Parekattil SJ. Update in the evaluation of the azoospermic male. Clinics (Sao Paulo). 2013;68 Suppl 1(Suppl 1):27-34. doi: 10.6061/clinics/2013(sup01)04. PubMed 23503952 ↗
  • Cocuzza M, Alvarenga C, Pagani R. The epidemiology and etiology of azoospermia. Clinics (Sao Paulo). 2013;68 Suppl 1(Suppl 1):15-26. doi: 10.6061/clinics/2013(sup01)03. PubMed 23503951 ↗
  • Sihag P, Tandon A, Pal R, Jain BK, Bhatt S, Kaur S, Sinha A. Sonography in male infertility: a look beyond the obvious. J Ultrasound. 2018 Sep;21(3):265-276. doi: 10.1007/s40477-018-0294-5. Epub 2018 Mar 28. PubMed 29594932 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 30, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05026190
Lead sponsor
Assiut University
Responsible party
Mohamed ElSharkawy (resident of urology, Assiut University) — Principal investigator
First posted
Aug 30, 2021
Start date
Oct 5, 2021 (estimated)
Primary completion
Dec 5, 2022 (estimated)
Completion
Dec 5, 2022 (estimated)
Last update
Aug 30, 2021

Study contacts

mohamed m elsharkawy
Contact
mohamed.20134308@med.au.edu.eg
01065811880

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion